4546 El Camino Real
Suite B1
Los Altos, CA 94022
United States
650 284 4433
https://renovorx.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 8
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Ramtin Agah M.D. | Founder, Chairman of Board & Chief Medical Officer | 332.89k | N/A | 1967 |
Mr. Shaun R. Bagai | CEO & Director | 589.38k | N/A | 1977 |
Mr. Ronald B. Kocak CPA, CGMA | VP, Controller & Principal Accounting Officer | N/A | N/A | 1957 |
Ms. Leesa Gentry | Chief Clinical Officer | N/A | N/A | 1970 |
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. The company was founded in 2009 and is headquartered in Los Altos, California.
RenovoRx, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.